DPDoctor's PassportEducation
Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.
RapidMLAMSRAGP

Rheumatological disease and uveitis

Essential points for quick revision.

!
Inflammatory disease does not explain away a painful red eye

Eye pain, redness, photophobia or blurred vision can indicate acute anterior uveitis. Infection and other ocular emergencies may produce similar symptoms, including in someone already receiving immunosuppression.

Action: Arrange immediate same-day ophthalmological assessment for symptoms of acute anterior uveitis, following NICE NG65. Sudden marked visual loss or a suspected posterior inflammatory emergency requires direct emergency eye-service contact.

Synopsis

Recognise inflammatory eye disease associated with rheumatological conditions, investigate relevant systemic clues and coordinate safe ocular treatment without overlooking infection.

  • Uveitis may be the first clue to systemic inflammatory disease, but many episodes lack an identified systemic cause.
  • Ask about inflammatory back pain, joint symptoms, psoriasis, bowel inflammation and recurrent oral or genital ulcers.
  • Describe which ocular structures are inflamed; anterior, intermediate, posterior and panuveitic disease require different assessment and treatment.

Key red flags

A painful red eye with light intolerance or reduced vision needs same-day ophthalmic assessment.

Investigation priorities

01
Slit-lamp examination with pressure assessmentFirst step

Confirm anterior inflammation and assess associated structural or pressure complications.

Management branches

Acute symptomsEstablish the ocular diagnosis today

Pain, redness, photophobia or blurred vision suggests acute anterior uveitis.

  1. Arrange same-day ophthalmological assessment, stating visual change, immune treatment and relevant systemic disease.
  2. Document available visual findings and medication exposure while avoiding empirical escalation of steroid for an undiagnosed red eye.

Key medicines

Pred Forte 1% prednisolone acetate suspension for specialist-confirmed inflammationThe adult UK product regimen is one or two drops in the affected eye two to four times daily; during the first 24–48 hours, two drops every hour may be prescribed. The ophthalmologist determines subsequent frequency, taper and stop point from inflammation control.
Open full textbook Answer 2 questions
Sources and review status6 sources · checked 7 Sept 2026 · clinical review pending
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 7 Sept 2026; clinical approval remains outstanding.

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom